These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9803782)

  • 1. [New prognostic factors in bronchogenic cancer].
    Navío Martín P; Pérez Rodríguez E; Sueiro Bendito A
    Rev Clin Esp; 1998 Sep; 198(9):604-9. PubMed ID: 9803782
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oncogenes, differentiation markers and morphological criteria as prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M; Junker K
    Dtsch Med Wochenschr; 1997 Oct; 122(43):1327-31. PubMed ID: 9410698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bronchial cancer. Mechanisms of bronchial oncogenesis].
    Krespine C
    Soins; 1994 Dec-1995 Jan; (591-592):3-4, 6. PubMed ID: 7652603
    [No Abstract]   [Full Text] [Related]  

  • 4. [New cell biology research on the development of bronchial cancer].
    Lorenz J
    Internist (Berl); 1994 Aug; 35(8):692-9. PubMed ID: 7960549
    [No Abstract]   [Full Text] [Related]  

  • 5. [From dysplasia to cancer: cytologic, histopathologic and molecular aspects].
    Vignaud JM
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S107-11. PubMed ID: 10088273
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biology of bronchial cancer. Anomalies of the cellular cycle].
    Larsen C
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S14-5. PubMed ID: 10088223
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic markers for stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N
    Lung Cancer; 2008 Feb; 59(2):274-5. PubMed ID: 18055061
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular markers of ovarian carcinoma].
    Dobryszycka W
    Postepy Hig Med Dosw; 2000; 54(4):495-518. PubMed ID: 11016269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic factors in the predisposition for bronchogenic carcinoma].
    Pesut D
    Plucne Bolesti; 1989; 41(1-2):35-8. PubMed ID: 2798569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics and bronchogenic carcinoma (author's transl)].
    Kohl FV; Rüdiger HW; von Wichert P
    Prax Klin Pneumol; 1977 May; 31(5):503-4. PubMed ID: 887608
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial aggregation of cancer in patients with bronchogenic carcinoma.
    Gupta D; Aggarwal AN; Vikrant S; Jindal SK
    Indian J Cancer; 2000 Mar; 37(1):43-9. PubMed ID: 11261236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New prognostic factors in lung cancer].
    Alvarez-Sala R; Prados C; Gómez L; Gómez de Terreros J; Alvarez-Sala JL
    Rev Clin Esp; 1999 Apr; 199(4):255. PubMed ID: 10364803
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic factors on surgical treatment for lung cancer].
    Sekine Y; Fujisawa T
    Kyobu Geka; 2003 Jul; 56(8 Suppl):722-7. PubMed ID: 12910959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer.
    Nieder C; Andratschke N; Jeremic B; Molls M
    Anticancer Res; 2003; 23(6D):5117-23. PubMed ID: 14981976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicaments in and prospects for lung cancer.
    Lillington GA
    Curr Opin Pulm Med; 1996 Jul; 2(4):261-2. PubMed ID: 9363149
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bronchial carcinoma caused by genetic and environmental factors: genetic factors].
    Nowak D
    Pneumologie; 1994 Aug; 48(8):526-8. PubMed ID: 7971891
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic tumor markers in non-small cell lung cancer.
    Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
    Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.